Clinical Studies and Therapies in Parkinson s Disease

This book PDF is perfect for those who love Medical genre, written by Juan Segura-Aguilar and published by Academic Press which was released on 12 June 2021 with total hardcover pages 306. You could read this book directly on your devices with pdf, epub and kindle format, check detail and related Clinical Studies and Therapies in Parkinson s Disease books below.

Clinical Studies and Therapies in Parkinson s Disease
Author : Juan Segura-Aguilar
File Size : 46,9 Mb
Publisher : Academic Press
Language : English
Release Date : 12 June 2021
ISBN : 9780128221587
Pages : 306 pages
Get Book

Clinical Studies and Therapies in Parkinson s Disease by Juan Segura-Aguilar Book PDF Summary

More than 50 years have passed since the use of L-dopa in the palliative treatment of Parkinson’s disease, but it remains the most common treatment despite inducing severe side effects such as dyskinesia after 4–6 years of use. Numerous preclinical investigations based on endogenous neurotoxin models have promised various therapies for Parkinson’s disease, but these efforts have failed when attempting to transfer these successful results to preclinical studies. Although several publications have warned of these failures, the scientific community remains mostly unaware, and there is a need to focus their efforts on potential therapeutics that can slow or halt development of the disease. Clinical Studies and Therapies in Parkinson’s Disease: Translations from Preclinical Models analyzes preclinical models based on exogenous neurotoxins and why they have failed. Neuroscientists, neurologists, and neuropharmacologists will benefit greatly from the book’s discussion of these newer models, their benefits, and the need for their implementation. This book also provides the basic concepts of dopamine metabolism for students taking courses in neurochemistry, neuroscience, neuropharmacology, biochemistry, and medicine. Reviews Parkinson's disease classification, pharmacological therapies, and nonmotor and motor symptoms Analyzes preclinical models of Parkinson’s disease therapies based on exogenous neurotoxins and why they have failed Reviews genetic preclinical models based on genetic mutations and endogenous neurotoxins Proposes a more physiological model directly related to the metabolism of dopaminergic neurons Provides the basic concepts and mechanisms of dopamine metabolism

Clinical Trials In Parkinson s Disease

This volume looks at major clinical trials for motor and non-motor symptoms in Parkinson’s Disease (PD) and covers important aspects, including trial design, sample selection, and outcome selection. Chapters in this book discuss topics such as toxin-based rodent or genetic models of PD; clinical trials for motor symptoms, L-DOPA

Get Book
Clinical Studies and Therapies in Parkinson s Disease

More than 50 years have passed since the use of L-dopa in the palliative treatment of Parkinson’s disease, but it remains the most common treatment despite inducing severe side effects such as dyskinesia after 4–6 years of use. Numerous preclinical investigations based on endogenous neurotoxin models have promised various therapies for

Get Book
The New Parkinson s Disease Treatment Book

The fundamental guide to the most effective treatments for Parkinson's Disease, from a Mayo Clinic doctor with thirty years of clinical and research experience. In this second edition follow-up to the extremely successful first edition, Dr. Ahlskog draws on thirty years of clinical experience to present the definitive guide to

Get Book
Etiology of Parkinson s Disease

This comprehensive reference provides a detailed overview of current concepts regarding the cause of Parkinson's disease-emphasizing the issues involved in the design, implementation, and analysis of epidemiological studies of parkinsonism.

Get Book
Non Motor Symptoms of Parkinson s Disease

Patients with Parkinson's disease (PD) are known to suffer from motor symptoms of the disease, but they also experience non-motor symptoms (NMS) that are often present before diagnosis or that inevitably emerge with disease progression. The motor symptoms of Parkinson's disease have been extensively researched, and effective clinical tools for

Get Book
Levodopa pharmacokinetics  from stomach to brain

Parkinson’s disease (PD) is one of the most common neurodegenerative disorders and it is caused by a loss of dopamine (DA) producing neurons in the basal ganglia in the brain. The PD patient suffers from motor symptoms such as tremor, bradykinesia and rigidity and treatment with levodopa (LD), the

Get Book
Clinical Trials In Parkinson s Disease

This volume looks at major clinical trials for motor and non-motor symptoms in Parkinson’s Disease (PD) and covers important aspects, including trial design, sample selection, and outcome selection. Chapters in this book discuss topics such as toxin-based rodent or genetic models of PD; clinical trials for motor symptoms, L-DOPA

Get Book
Diagnosis and Treatment of Parkinson s Disease

Download or read online Diagnosis and Treatment of Parkinson s Disease written by Cindy Levine, published by Department of Health and Human Services Pu Ncy for Healthcare Res which was released on 2003-01-01. Get Diagnosis and Treatment of Parkinson s Disease Books now! Available in PDF, ePub and Kindle.

Get Book